Cardiometabolic risk factors and atrial fibrillation

Area of Science:

• Cardiology
• Metabolic Diseases
• Electrophysiology

Background:

• Atrial fibrillation (AF) is the most prevalent arrhythmia globally, posing significant risks for stroke and impacting cardiac function.
• Despite its clinical importance, the underlying causes and mechanisms of AF remain incompletely understood.
• Existing research suggests a strong association between AF and metabolic syndrome (MetS).

Purpose of the Study:

• To review the relationship between metabolic syndrome (MetS) and atrial fibrillation (AF).
• To examine how individual components of MetS influence the occurrence and progression of AF.
• To provide a comprehensive overview of the current understanding of MetS's impact on AF.

Main Methods:

• Literature review of studies investigating the link between MetS and AF.
• Analysis of epidemiological data and clinical research findings.
• Synthesis of evidence on the pathophysiological mechanisms involved.

Main Results:

• Metabolic syndrome is frequently observed in patients with atrial fibrillation.
• Specific components of MetS, such as obesity, hypertension, and diabetes, show a particularly strong correlation with AF.
• The interplay between metabolic dysregulation and cardiac electrophysiology contributes to AF development.

Conclusions:

• Metabolic syndrome is a significant contributing factor to atrial fibrillation.
• Understanding the specific roles of MetS components is crucial for developing targeted prevention and treatment strategies for AF.
• Further research into the mechanistic links between metabolic health and cardiac arrhythmias is warranted.